Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
In part two of our AACR 2026 coverage, industry leaders were focussed on how the field is no longer constrained by data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results